A citation-based method for searching scientific literature

Aouatef Riahi, Abdelmonem Messaoudi, Ridha Mrad, Asma Fourati, Habiba Chabouni-Bouhamed, Maher Kharrat. J Theor Biol 2016
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Next-generation sequencing of BRCA1 and BRCA2 in breast cancer patients and control subjects.
Lubomir Balabanski, Georgi Antov, Ivanka Dimova, Samuil Ivanov, Maria Nacheva, Ivan Gavrilov, Desislava Nesheva, Blaga Rukova, Savina Hadjidekova, Maxim Malinov,[...]. Mol Clin Oncol 2014
8
50


Increased prevalence of the BRCA2 polymorphic stop codon K3326X among individuals with familial pancreatic cancer.
Sean T Martin, Hiroyuki Matsubayashi, Carmelle D Rogers, Juliet Philips, Fergus J Couch, Kieran Brune, Charles J Yeo, Scott E Kern, Ralph H Hruban, Michael Goggins. Oncogene 2005
59
50

Association of BRCA2 K3326* With Small Cell Lung Cancer and Squamous Cell Cancer of the Skin.
Thorunn Rafnar, Gudbjorg R Sigurjonsdottir, Simon N Stacey, Gisli Halldorsson, Patrick Sulem, Luba M Pardo, Hannes Helgason, Stefan T Sigurdsson, Thorkell Gudjonsson, Laufey Tryggvadottir,[...]. J Natl Cancer Inst 2018
13
50


Truncated BRCA2 is cytoplasmic: implications for cancer-linked mutations.
B H Spain, C J Larson, L S Shihabuddin, F H Gage, I M Verma. Proc Natl Acad Sci U S A 1999
108
50

RAD-ical New Insights into RAD51 Regulation.
Meghan R Sullivan, Kara A Bernstein. Genes (Basel) 2018
39
50

Reevaluation of the BRCA2 truncating allele c.9976A > T (p.Lys3326Ter) in a familial breast cancer context.
Ella R Thompson, Kylie L Gorringe, Simone M Rowley, Na Li, Simone McInerny, Michelle W Wong-Brown, Lisa Devereux, Jason Li, Alison H Trainer, Gillian Mitchell,[...]. Sci Rep 2015
17
50

Variants in the GH-IGF axis confer susceptibility to lung cancer.
Matthew F Rudd, Emily L Webb, Athena Matakidou, Gabrielle S Sellick, Richard D Williams, Helen Bridle, Tim Eisen, Richard S Houlston. Genome Res 2006
93
50

A protective role for BRCA2 at stalled replication forks.
Gurushankar Chandramouly, Nicholas A Willis, Ralph Scully. Breast Cancer Res 2011
4
50

ATM activation and its recruitment to damaged DNA require binding to the C terminus of Nbs1.
Zhongsheng You, Charly Chahwan, Julie Bailis, Tony Hunter, Paul Russell. Mol Cell Biol 2005
314
50

Genome-wide meta-analysis identifies eight new susceptibility loci for cutaneous squamous cell carcinoma.
Kavita Y Sarin, Yuan Lin, Roxana Daneshjou, Andrey Ziyatdinov, Gudmar Thorleifsson, Adam Rubin, Luba M Pardo, Wenting Wu, Paul A Khavari, Andre Uitterlinden,[...]. Nat Commun 2020
7
50

The checkpoint kinases Chk1 and Chk2 regulate the functional associations between hBRCA2 and Rad51 in response to DNA damage.
E M Bahassi, J L Ovesen, A L Riesenberg, W Z Bernstein, P E Hasty, P J Stambrook. Oncogene 2008
107
50

Distinct binding of BRCA2 BRC repeats to RAD51 generates differential DNA damage sensitivity.
Gouri Chatterjee, Judit Jimenez-Sainz, Thomas Presti, Tiffany Nguyen, Ryan B Jensen. Nucleic Acids Res 2016
29
50

Mapping the physical and functional interactions between the tumor suppressors p53 and BRCA2.
Sridharan Rajagopalan, Antonina Andreeva, Trevor J Rutherford, Alan R Fersht. Proc Natl Acad Sci U S A 2010
33
50

A Functional Analysis of the Unclassified Pro2767Ser BRCA2 Variant Reveals Its Potential Pathogenicity that Acts by Hampering DNA Binding and Homology-Mediated DNA Repair.
Maria Valeria Esposito, Giuseppina Minopoli, Luciana Esposito, Valeria D'Argenio, Federica Di Maggio, Emanuele Sasso, Massimiliano D'Aiuto, Nicola Zambrano, Francesco Salvatore. Cancers (Basel) 2019
3
50

Segregation analysis of the BRCA2 c.9227G>T variant in multiple families suggests a pathogenic role in breast and ovarian cancer predisposition.
Simona Agata, Silvia Tognazzo, Elisa Alducci, Laura Matricardi, Lidia Moserle, Daniela Barana, Marco Montagna. Sci Rep 2020
2
50

Mutations in Fanconi anemia genes and the risk of esophageal cancer.
Mohammad R Akbari, Reza Malekzadeh, Pierre Lepage, David Roquis, Ali R Sadjadi, Karim Aghcheli, Abbas Yazdanbod, Ramin Shakeri, Jafar Bashiri, Masoud Sotoudeh,[...]. Hum Genet 2011
31
50

BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers.
Huong D Meeks, Honglin Song, Kyriaki Michailidou, Manjeet K Bolla, Joe Dennis, Qin Wang, Daniel Barrowdale, Debra Frost, Lesley McGuffog, Steve Ellis,[...]. J Natl Cancer Inst 2015
62
50

Protein dynamics of human RPA and RAD51 on ssDNA during assembly and disassembly of the RAD51 filament.
Chu Jian Ma, Bryan Gibb, YoungHo Kwon, Patrick Sung, Eric C Greene. Nucleic Acids Res 2017
67
50

Cancer susceptibility of mice with a homozygous deletion in the COOH-terminal domain of the Brca2 gene.
Kimberly A McAllister, L Michelle Bennett, Chris D Houle, Toni Ward, Jason Malphurs, N Keith Collins, Carol Cachafeiro, Joseph Haseman, Eugenia H Goulding, Donna Bunch,[...]. Cancer Res 2002
77
50

The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data.
Ethan Cerami, Jianjiong Gao, Ugur Dogrusoz, Benjamin E Gross, Selcuk Onur Sumer, Bülent Arman Aksoy, Anders Jacobsen, Caitlin J Byrne, Michael L Heuer, Erik Larsson,[...]. Cancer Discov 2012
50

Interactions between human BRCA2 protein and the meiosis-specific recombinase DMC1.
Tina Thorslund, Fumiko Esashi, Stephen C West. EMBO J 2007
77
50

Identification and evaluation of 55 genetic variations in the BRCA1 and the BRCA2 genes of patients from 50 Japanese breast cancer families.
Masanori Kawahara, Masato Sakayori, Kazuko Shiraishi, Tadashi Nomizu, Motohiro Takeda, Rikiya Abe, Noriaki Ohuchi, Seiichi Takenoshita, Chikashi Ishioka. J Hum Genet 2004
12
50

ATM-Dependent Phosphorylation of All Three Members of the MRN Complex: From Sensor to Adaptor.
Martin F Lavin, Sergei Kozlov, Magtouf Gatei, Amanda W Kijas. Biomolecules 2015
76
50

Deletion of BRCA2 exon 27 causes defects in response to both stalled and collapsed replication forks.
Tae Moon Kim, Mi Young Son, Sherry Dodds, Lingchuan Hu, Paul Hasty. Mutat Res 2014
9
50

Double-strand break repair-independent role for BRCA2 in blocking stalled replication fork degradation by MRE11.
Katharina Schlacher, Nicole Christ, Nicolas Siaud, Akinori Egashira, Hong Wu, Maria Jasin. Cell 2011
701
50

Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal.
Jianjiong Gao, Bülent Arman Aksoy, Ugur Dogrusoz, Gideon Dresdner, Benjamin Gross, S Onur Sumer, Yichao Sun, Anders Jacobsen, Rileen Sinha, Erik Larsson,[...]. Sci Signal 2013
50

Mouse embryonic stem cell-based functional assay to evaluate mutations in BRCA2.
Sergey G Kuznetsov, Pentao Liu, Shyam K Sharan. Nat Med 2008
92
50

The MRN complex in double-strand break repair and telomere maintenance.
Brandon J Lamarche, Nicole I Orazio, Matthew D Weitzman. FEBS Lett 2010
234
50

Nuclear localization signals of the BRCA2 protein.
K Yano, K Morotomi, H Saito, M Kato, F Matsuo, Y Miki. Biochem Biophys Res Commun 2000
43
50

Comprehensive genetic characterization of hereditary breast/ovarian cancer families from Slovakia.
Michal Konecny, Miriam Milly, Katarina Zavodna, Eva Weismanova, Jaroslava Gregorova, Iveta Mlkva, Denisa Ilencikova, Juraj Kausitz, Zdena Bartosova. Breast Cancer Res Treat 2011
15
50

BRCA1 and BRCA2 unclassified variants and missense polymorphisms in Algerian breast/ovarian cancer families.
Farid Cherbal, Nadjet Salhi, Rabah Bakour, Saida Adane, Kada Boualga, Philippe Maillet. Dis Markers 2012
16
50

Germline BRCA2 K3326X and CHEK2 I157T mutations increase risk for sporadic pancreatic ductal adenocarcinoma.
O Obazee, L Archibugi, A Andriulli, P Soucek, E Małecka-Panas, A Ivanauskas, T Johnson, M Gazouli, T Pausch, R T Lawlor,[...]. Int J Cancer 2019
11
50

Large BRCA1 and BRCA2 genomic rearrangements in Danish high risk breast-ovarian cancer families.
Thomas v O Hansen, Lars Jønson, Anders Albrechtsen, Mette K Andersen, Bent Ejlertsen, Finn C Nielsen. Breast Cancer Res Treat 2009
50
50

The functional impact of variants of uncertain significance in BRCA2.
Romy L S Mesman, Fabienne M G R Calléja, Giel Hendriks, Bruno Morolli, Branislav Misovic, Peter Devilee, Christi J van Asperen, Harry Vrieling, Maaike P G Vreeswijk. Genet Med 2019
30
50

Germline variants in DNA repair genes associated with hereditary breast and ovarian cancer syndrome: analysis of a 21 gene panel in the Brazilian population.
Simone da Costa E Silva Carvalho, Nathalia Moreno Cury, Danielle Barbosa Brotto, Luiza Ferreira de Araujo, Reginaldo Cruz Alves Rosa, Lorena Alves Texeira, Jessica Rodrigues Plaça, Adriana Aparecida Marques, Kamila Chagas Peronni, Patricia de Cássia Ruy,[...]. BMC Med Genomics 2020
9
50



Regulation of PCNA-protein interactions for genome stability.
Niels Mailand, Ian Gibbs-Seymour, Simon Bekker-Jensen. Nat Rev Mol Cell Biol 2013
233
50

ATM phosphorylates histone H2AX in response to DNA double-strand breaks.
S Burma, B P Chen, M Murphy, A Kurimasa, D J Chen. J Biol Chem 2001
50

The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds.
S V Tavtigian, J Simard, J Rommens, F Couch, D Shattuck-Eidens, S Neuhausen, S Merajver, S Thorlacius, K Offit, D Stoppa-Lyonnet,[...]. Nat Genet 1996
664
50

A computational model for classification of BRCA2 variants using mouse embryonic stem cell-based functional assays.
Kajal Biswas, Gary B Lipton, Stacey Stauffer, Teresa Sullivan, Linda Cleveland, Eileen Southon, Susan Reid, Valentin Magidson, Edwin S Iversen, Shyam K Sharan. NPJ Genom Med 2020
3
50

Germline and somatic mutations in homologous recombination genes predict platinum response and survival in ovarian, fallopian tube, and peritoneal carcinomas.
Kathryn P Pennington, Tom Walsh, Maria I Harrell, Ming K Lee, Christopher C Pennil, Mara H Rendi, Anne Thornton, Barbara M Norquist, Silvia Casadei, Alexander S Nord,[...]. Clin Cancer Res 2014
496
50

BRCA2 is required for homology-directed repair of chromosomal breaks.
M E Moynahan, A J Pierce, M Jasin. Mol Cell 2001
691
50

Structural analysis of the chicken BRCA2 gene facilitates identification of functional domains and disease causing mutations.
Madhuri Warren, Amanda Smith, Natalie Partridge, Julio Masabanda, Darren Griffin, Alan Ashworth. Hum Mol Genet 2002
40
50


Can multiple SNP testing in BRCA2 and BRCA1 female carriers be used to improve risk prediction models in conjunction with clinical assessment?
Mattia C F Prosperi, Sarah L Ingham, Anthony Howell, Fiona Lalloo, Iain E Buchan, Dafydd Gareth Evans. BMC Med Inform Decis Mak 2014
4
50

ClinVar: improving access to variant interpretations and supporting evidence.
Melissa J Landrum, Jennifer M Lee, Mark Benson, Garth R Brown, Chen Chao, Shanmuga Chitipiralla, Baoshan Gu, Jennifer Hart, Douglas Hoffman, Wonhee Jang,[...]. Nucleic Acids Res 2018
887
50

BRCA2 loss-of-function germline mutations are associated with esophageal squamous cell carcinoma risk in Chinese.
Josephine Mun-Yee Ko, Lvwen Ning, Xue-Ke Zhao, Annie Wai Yeeng Chai, Lisa Chan Lei, Sheyne Sta Ana Choi, Lihua Tao, Simon Law, Ava Kwong, Nikki Pui-Yue Lee,[...]. Int J Cancer 2020
12
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.